Phage display technology: clinical applications and recent innovations

被引:225
作者
Azzazy, HME
Highsmith, WE
机构
[1] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med & Res Technol, Baltimore, MD 21201 USA
关键词
phage display; single-chain variable fragments; phage-peptide; immuno-diagnostics; recombinant antibodies; panning; bispecific antibodies;
D O I
10.1016/S0009-9120(02)00343-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Phage display is a molecular diversity technology that allows the presentation of large peptide and protein libraries on the surface of filamentous phage. Phage display libraries permit the selection of peptides and proteins, including antibodies, with high affinity and specificity for almost any target. A crucial advantage of this technology is the direct link that exists between the experimental phenotype and its encapsulated genotype, which allows the evolution of the selected binders into optimized molecules. Phage display facilitates engineering of antibodies with regard to their size, valency, affinity, and effector functions. The selection of antibodies and peptides from libraries displayed on the surface of filamentous phage has proven significant for routine isolation of peptides and antibodies for diagnostic and therapeutic applications. This review serves as an introduction to phage display, antibody engineering, the development of phage-displayed peptides and antibody fragments into viable diagnostic reagents, and recent trends in display technology. (C) 2002 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:425 / 445
页数:21
相关论文
共 160 条
[1]   CHARACTERIZATION OF PHAGE THAT BIND PLASTIC FROM PHAGE-DISPLAYED RANDOM PEPTIDE LIBRARIES [J].
ADEY, NB ;
MATARAGNON, AH ;
RIDER, JE ;
CARTER, JM ;
KAY, BK .
GENE, 1995, 156 (01) :27-31
[2]  
AKAMATSU Y, 1993, J IMMUNOL, V151, P4651
[3]   ANTIGEN-BINDING PROPERTIES OF HIGHLY PURIFIED BISPECIFIC ANTIBODIES [J].
ALLARD, WJ ;
MORAN, CA ;
NAGEL, E ;
COLLINS, G ;
LARGEN, MT .
MOLECULAR IMMUNOLOGY, 1992, 29 (10) :1219-1227
[4]   A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells [J].
Andersen, PS ;
Stryhn, A ;
Hansen, BE ;
Fugger, L ;
Engberg, J ;
Buus, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1820-1824
[5]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[6]   scFv multimers of the anti-neuraminidase antibody NC10:: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies [J].
Atwell, JL ;
Breheney, KA ;
Lawrence, LJ ;
McCoy, AJ ;
Kortt, AA ;
Hudson, PJ .
PROTEIN ENGINEERING, 1999, 12 (07) :597-604
[7]   ANTIBODY ENGINEERING BY PARSIMONIOUS MUTAGENESIS [J].
BALINT, RF ;
LARRICK, JW .
GENE, 1993, 137 (01) :109-118
[8]  
Barbas Carlos F. Iii, 1993, Current Opinion in Biotechnology, V4, P526, DOI 10.1016/0958-1669(93)90072-5
[9]   ASSEMBLY OF COMBINATORIAL ANTIBODY LIBRARIES ON PHAGE SURFACES - THE GENE-III SITE [J].
BARBAS, CF ;
KANG, AS ;
LERNER, RA ;
BENKOVIC, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) :7978-7982
[10]   ESCHERICHIA-COLI SECRETION OF AN ACTIVE CHIMERIC ANTIBODY FRAGMENT [J].
BETTER, M ;
CHANG, CP ;
ROBINSON, RR ;
HORWITZ, AH .
SCIENCE, 1988, 240 (4855) :1041-1043